OOIR: Observatory of International Research

Papers

(The TQCC of Biochemia Medica is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies	411
Inflammatory and angiogenic biomarkers in diabetic retinopathy	82
Complete blood count alterations in COVID-19 patients	67
Errors within the total laboratory testing process, from test selection to medical decision-making – A review of causes, consequences, surveillance and solutions	30
Rate of re-positive RT-PCR test among patients recovered from COVID-19	26
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG	22
The top-down approach to measurement uncertainty	16
Analysis of single comments left for bioRxiv preprints till September 2019	15
Performance of D-dimer for predicting sepsis mortality in the intensive care unit	15
Analytical bias of automated immunoassays for six serum steroid hormones assessed by LC-MS/MS	14
Analysis of serum homocysteine in the laboratory practice - comparison of the direct chemiluminescence immunoassay and high performance liquid chromatography coupled with fluorescent detection	13
In sickness and in health: pivotal role of vitamin D	12
Current status of the lateral flow immunoassay for the detection of SARS-CoV-2 in nasopharyngeal swabs	12
Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine	11
Using clinical guidelines to assess the potential value of laboratory medicine in clinical decision-making	10
Evaluation of the clinical chemistry tests analytical performance with Sigma Metric by using different quality specifications - Comparison of analyser actual performance with manufacturer data	9
The apparent prevalence, the true prevalence	9
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer	9
Comparison of diagnostic accuracy for eight SARS-CoV-2 serological assays	8
Wilfully submitting to and publishing in predatory journals - a covert form of research misconduct?	8
Before and after enforcement of GDPR	8
Improved protocol for plasma microRNA extraction and comparison of commercial kits	8
Evaluation of a new equation for estimating low-density lipoprotein cholesterol through the comparison with various recommended methods	8
Seroprevalence of SARS-CoV-2 infection among children in Children’s Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia	7
Impact of combining data from multiple instruments on performance of patient-based real-time quality control	6

Indirect reference intervals for haematological parameters in capillary blood of pre-school children	6
The rise in preanalytical errors during COVID-19 pandemic	6
Verification of automated latex-enhanced particle immunoturbidimetric D-Dimer assays on different analytical platforms and comparability of test results	6
Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?	6
Verification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents	6
Order of draw of blood samples affect potassium results without K-EDTA contamination during routine workflow	6
Early markers of gestational diabetes mellitus	6
Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000	5
SARS-CoV-2 – a new challenge for laboratory medicine	5
Pre-amplification as a method for improvement of quantitative RT-PCR analysis of circulating miRNAs	5
Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice	5
Clinical importance of laboratory biomarkers in liver fibrosis	5
Changes in error rates in the Australian key incident monitoring and management system program	5
Utility of icteric index in clinical laboratories: more than a preanalytical indicator	5
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis	5
Utilization of biological variation data in the interpretation of laboratory test results – survey about clinicians’ opinion and knowledge	5
Recommendations for the application and follow-up of quality controls in medical laboratories	5
Estimation of the measurement uncertainty and practical suggestion for the description of the metrological traceability in clinical laboratories	5
Laboratory markers included in the Corona Score can identify false negative results on COVID-19 RT-PCR in the emergency room	4
The response of total testing process in clinical laboratory medicine to COVID-19 pandemic	4
Analytical performance assessment and improvement by means of the Failure mode and effect analysis (FMEA)	4
Antipsychotics-induced hyperprolactinemia and screening for macroprolactin	4
Comparison of Freelite and N-Latex serum free light chain assays	4
Circulatory cytokeratin 17, marginal zone B1 protein and leucine-rich α2-glycoprotein-1 as biomarkers for disease severity and fibrosis in systemic sclerosis patients	4
Diagnostic challenges of diabetic kidney disease	4
General position of Croatian medical biochemistry laboratories on autovalidation	4
Establishment of gender- and age-specific reference intervals for serum liver function tests among the elderly population in northeast China	4
Case report of a phantom pheochromocytoma	4
Detection of preanalytical errors in arterial blood gas analysis	4
Long-term stability of clinically relevant chemistry analytes in pleural and peritoneal fluid	4